These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 8747080

  • 1. Biological markers in inflammatory rheumatic diseases.
    Hilliquin P.
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
    [Abstract] [Full Text] [Related]

  • 2. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L, Nozzi M, De Sanctis S, Chiarelli F.
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [Abstract] [Full Text] [Related]

  • 3. Validity of acute phase proteins as markers of disease activity.
    Blackburn WD.
    J Rheumatol Suppl; 1994 Oct; 42():9-13. PubMed ID: 7529838
    [Abstract] [Full Text] [Related]

  • 4. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H.
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [Abstract] [Full Text] [Related]

  • 5. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 6. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C, Wetterö J.
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [Abstract] [Full Text] [Related]

  • 7. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 8. [Antinuclear antibodies in rheumatology].
    Zuber M.
    Z Rheumatol; 1994 Feb; 53(6):327-34. PubMed ID: 7871904
    [Abstract] [Full Text] [Related]

  • 9. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardieri S, Migliorini P.
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [Abstract] [Full Text] [Related]

  • 10. Clinical utility of common serum rheumatologic tests.
    Lane SK, Gravel JW.
    Am Fam Physician; 2002 Mar 15; 65(6):1073-80. PubMed ID: 11925083
    [Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of immuno-serological laboratory data].
    Kasukawa R, Tojo J, Kuwana T, Obara K.
    Rinsho Byori; 1996 Dec 15; 44(12):1157-63. PubMed ID: 8990934
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb 15; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 13. [Immunopathologic mechanism in some ocular diseases].
    Rogoz S, Avramescu C, Siloşi I, Drackoulogona O, Badea P, State A.
    Oftalmologia; 2002 Feb 15; 54(3):51-5. PubMed ID: 12723199
    [Abstract] [Full Text] [Related]

  • 14. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
    Schett G, Dumortier H, Hoefler E, Muller S, Steiner G.
    Ann Rheum Dis; 2009 May 15; 68(5):729-35. PubMed ID: 18495733
    [Abstract] [Full Text] [Related]

  • 15. [Clinical utility of serum diagnostic tests for rheumatic diseases].
    Mindlin A.
    Rev Med Brux; 2007 Sep 15; 28(4):302-7. PubMed ID: 17958025
    [Abstract] [Full Text] [Related]

  • 16. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM, Amoura Z, Johannet C, Jeronimo AL, Campos H, Koutouzov S, Piette JC, Bach JF.
    Arthritis Rheum; 2000 Mar 15; 43(3):689-98. PubMed ID: 10728764
    [Abstract] [Full Text] [Related]

  • 17. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G.
    J Clin Invest; 1997 Jul 01; 100(1):127-35. PubMed ID: 9202064
    [Abstract] [Full Text] [Related]

  • 18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct 01; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 19. [Study of antihistone and anti-bicatenary RNA antibodies in connective tissue diseases using immunoenzyme technic].
    Gioud M, Ait Kaci A, Sepetjan M, Monier JC.
    Rev Rhum Mal Osteoartic; 1982 Apr 01; 49(5):385-91. PubMed ID: 7100807
    [Abstract] [Full Text] [Related]

  • 20. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P, Batko B, Skura A, Adamek-Guzik T, Cześnikiewicz-Guzik M, Krzanowski M, Rydz-Stryszowska I, Ryszawa N, Guzik TJ.
    Przegl Lek; 2006 Apr 01; 63(5):278-83. PubMed ID: 17036505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.